Abstract
The future of HLA matching in solid organ transplantation lies in epitope matching. The article by Sapir-Pichhadze et al. provides indirect evidence that there is a difference in immunogenicity between antibody-verified versus non-verified eplets. However, this difference was less clear for HLA class II, showing the need for additional efforts to identify truly immunogenic HLA class II epitope mismatches.
| Original language | English |
|---|---|
| Pages (from-to) | 653-655 |
| Number of pages | 3 |
| Journal | Kidney International |
| Volume | 97 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Apr 2020 |
| Externally published | Yes |
Bibliographical note
Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.Fingerprint
Dive into the research topics of 'Not all HLA epitope mismatches are equal'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver